Michael Ha
Stock Analyst at Baird
(0.77)
# 3,876
Out of 4,918 analysts
51
Total ratings
22.58%
Success rate
-12.15%
Average return
Main Sectors:
Stocks Rated by Michael Ha
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Downgrades: Underperform | $312 → $198 | $237.77 | -16.73% | 6 | Jul 31, 2025 | |
| THC Tenet Healthcare | Maintains: Neutral | $195 → $167 | $158.09 | +5.64% | 3 | Jul 25, 2025 | |
| MOH Molina Healthcare | Maintains: Neutral | $373 → $179 | $155.13 | +15.39% | 4 | Jul 25, 2025 | |
| HUM Humana | Maintains: Neutral | $300 → $297 | $247.26 | +20.12% | 6 | Jul 25, 2025 | |
| ELV Elevance Health | Maintains: Neutral | $492 → $297 | $274.66 | +8.13% | 6 | Jul 25, 2025 | |
| CNC Centene | Maintains: Neutral | $68 → $28 | $25.91 | +8.07% | 4 | Jul 25, 2025 | |
| OSCR Oscar Health | Downgrades: Neutral | $28 → $14 | $13.58 | +3.09% | 2 | Jul 25, 2025 | |
| PRVA Privia Health Group | Maintains: Outperform | $24 → $26 | $18.86 | +37.86% | 3 | Apr 15, 2025 | |
| CVS CVS Health | Maintains: Neutral | $51 → $71 | $62.47 | +13.65% | 2 | Apr 15, 2025 | |
| CI The Cigna Group | Maintains: Outperform | $388 → $362 | $262.23 | +38.05% | 2 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $22 | $12.97 | +69.62% | 3 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $274 → $224 | $162.98 | +37.44% | 4 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $396 → $336 | $356.97 | -5.87% | 2 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $86 → $50 | $21.57 | +131.80% | 4 | Mar 3, 2025 |
UnitedHealth Group
Jul 31, 2025
Downgrades: Underperform
Price Target: $312 → $198
Current: $237.77
Upside: -16.73%
Tenet Healthcare
Jul 25, 2025
Maintains: Neutral
Price Target: $195 → $167
Current: $158.09
Upside: +5.64%
Molina Healthcare
Jul 25, 2025
Maintains: Neutral
Price Target: $373 → $179
Current: $155.13
Upside: +15.39%
Humana
Jul 25, 2025
Maintains: Neutral
Price Target: $300 → $297
Current: $247.26
Upside: +20.12%
Elevance Health
Jul 25, 2025
Maintains: Neutral
Price Target: $492 → $297
Current: $274.66
Upside: +8.13%
Centene
Jul 25, 2025
Maintains: Neutral
Price Target: $68 → $28
Current: $25.91
Upside: +8.07%
Oscar Health
Jul 25, 2025
Downgrades: Neutral
Price Target: $28 → $14
Current: $13.58
Upside: +3.09%
Privia Health Group
Apr 15, 2025
Maintains: Outperform
Price Target: $24 → $26
Current: $18.86
Upside: +37.86%
CVS Health
Apr 15, 2025
Maintains: Neutral
Price Target: $51 → $71
Current: $62.47
Upside: +13.65%
The Cigna Group
Apr 15, 2025
Maintains: Outperform
Price Target: $388 → $362
Current: $262.23
Upside: +38.05%
Apr 15, 2025
Maintains: Outperform
Price Target: $17 → $22
Current: $12.97
Upside: +69.62%
Apr 15, 2025
Downgrades: Neutral
Price Target: $274 → $224
Current: $162.98
Upside: +37.44%
Apr 15, 2025
Downgrades: Neutral
Price Target: $396 → $336
Current: $356.97
Upside: -5.87%
Mar 3, 2025
Maintains: Outperform
Price Target: $86 → $50
Current: $21.57
Upside: +131.80%